Women's Mental Health Psychiatry in FL & SC

The short answer

Stedfast Psychiatry provides women's mental health care including perinatal and postpartum depression and anxiety, premenstrual dysphoric disorder (PMDD), perimenopausal mood and sleep changes, and trauma-related conditions. Treatment combines medication chosen for pregnancy and breastfeeding safety, psychotherapy, and coordination with your OB/GYN. Available in person at 13 offices or by video in Florida and South Carolina.

Stedfast Psychiatry treats women across Florida and South Carolina with attention to where they are in that cycle. We coordinate with OB/GYNs, midwives and primary care physicians, choose medications with pregnancy and breastfeeding safety in mind, and take trauma histories seriously. Care is available at all 13 offices and by video.

Who it is for

Women planning a pregnancy who are on psychiatric medication and want to know what to do. Women who are pregnant and depressed or anxious, or who have a history of depression and are worried about the postpartum period. New mothers who are not sleeping even when the baby sleeps, who feel nothing, who are having frightening intrusive thoughts, or who are crying every day past the first two weeks. Women whose mood, irritability and anxiety spike predictably in the week before their period and resolve when it starts. Women in their forties and fifties with new insomnia, anxiety, low mood or brain fog alongside changing cycles or hot flashes.

It is also for women with a history of sexual assault, abuse or birth trauma that is affecting mood, sleep, relationships or sexual health, and for women with eating disorders, ADHD diagnosed late, or depression that has not responded to treatment. You do not need a referral, although many patients come to us from an OB/GYN.

How it works

The evaluation follows our standard structured interview with additions specific to reproductive mental health: menstrual history and the timing of symptoms relative to the cycle, pregnancy history including losses, postpartum history after any prior births, contraception and its effect on mood, menopausal symptoms, and a trauma history taken at a pace you control. We use the Edinburgh Postnatal Depression Scale for perinatal patients alongside the PHQ-9 and GAD-7, and for suspected PMDD we ask you to track symptoms across two cycles with a daily rating form, because the diagnosis depends on timing that memory gets wrong.

Treatment depends on the condition and stage. For perinatal depression and anxiety, sertraline is the most studied antidepressant in pregnancy and breastfeeding and is usually the first choice; we weigh the risks of medication against the well-documented risks of untreated depression in pregnancy, and we document that conversation. For PMDD, an SSRI taken either continuously or only during the luteal phase is effective for most women, and some do better with a hormonal approach coordinated with their gynecologist. For perimenopausal mood changes, options include antidepressants, CBT-I for sleep, and, in coordination with the OB/GYN, hormone therapy where appropriate. For trauma, trauma-focused therapy is central and medication supports it.

Coordination is built in. With your permission we communicate with your OB/GYN or midwife on medication choices during pregnancy, share our plan before delivery so the hospital team knows it, and align with your gynecologist on hormonal treatments that affect mood. Psychotherapy, including CBT, interpersonal therapy for perinatal depression and trauma-focused therapy, is available with our therapists.

About 1 in 8 women experience symptoms of postpartum depression, and the rate is higher in some states and populations.

Source: CDC, Pregnancy Risk Assessment Monitoring System

Premenstrual dysphoric disorder affects an estimated 3 to 8 percent of women of reproductive age.

Source: American College of Obstetricians and Gynecologists; Epperson et al., American Journal of Psychiatry, 2012

Women are nearly twice as likely as men to be diagnosed with depression and anxiety disorders over their lifetime.

Source: NIMH; Kessler et al., National Comorbidity Survey Replication

The risk of a new depressive episode roughly doubles during the menopausal transition compared with the premenopausal years.

Source: Study of Women's Health Across the Nation (SWAN); Bromberger et al., 2011

What to expect

A new-patient evaluation is 60 minutes, in person or by video for patients in Florida or South Carolina. Bring a list of medications including contraception and supplements, your OB/GYN's name, and, if pregnant, your due date and any complications. Partners are welcome at perinatal visits. Follow-ups are every two to four weeks while treatment is being adjusted and more frequent around delivery and the early postpartum weeks, when risk is highest.

For postpartum patients we try to see you within days, not weeks, and video visits make that feasible with a newborn at home. For PMDD, expect two cycles of symptom tracking before a confident diagnosis, with treatment often started in parallel. For perimenopause, expect a joint plan with your gynecologist. Therapy, if part of the plan, is weekly and can be by video.

Benefits

Clinicians experienced in perinatal, premenstrual and menopausal mood disorders
Medication choices informed by pregnancy and breastfeeding safety data
Direct coordination with your OB/GYN, midwife or primary care physician
Fast access for postpartum patients, including video from home
Trauma-informed evaluation and trauma-focused therapy
Symptom tracking that distinguishes PMDD from other conditions
Available at 13 offices or by video in Florida and South Carolina

Risks and side effects

Medication during pregnancy and breastfeeding is a risk-benefit decision, not a yes or no. Most SSRIs are not associated with major birth defects; some studies show small increases in specific risks, and newborns exposed late in pregnancy can have temporary adaptation symptoms such as jitteriness. Untreated depression in pregnancy is associated with preterm birth, low birth weight, poor prenatal care and postpartum depression, and untreated postpartum depression affects infant development. We go through the evidence with you and document the decision. Some medications, including valproate and, in most cases, paroxetine, are avoided in women who could become pregnant.

SSRIs used for PMDD carry the usual SSRI effects, which are fewer with luteal-phase-only dosing. Hormone therapy for perimenopause has its own risk profile managed by your gynecologist. Trauma-focused therapy can temporarily increase distress before it reduces it. Postpartum psychosis is rare but is a medical emergency: confusion, hallucinations, or thoughts of harming the baby require immediate care through 911 or the emergency department.

Cost and insurance

Women's mental health visits are billed as standard psychiatric evaluation, medication management and psychotherapy, which most commercial insurance plans and Medicare cover under behavioral health benefits at your copay or coinsurance. Pregnancy-related mental health care is covered by most plans and by Medicaid during pregnancy and the postpartum period; Medicaid participation varies by clinician and office, so ask when scheduling.

The self-pay rate for a new-patient evaluation is $185, with lower rates for follow-ups and therapy. Coordination with your OB/GYN, letters for employers regarding leave, and symptom tracking tools are included. Labs, if ordered, are billed by the laboratory. Newer perinatal-specific medications such as zuranolone may require prior authorization, which we handle.

Planning a pregnancy on psychiatric medication

The best time to make medication decisions is before conception. Some medications should be changed in advance; most can be continued. Stopping an effective antidepressant abruptly because of a positive test is the most common mistake we see, and it leads to relapse in a large share of women with a history of recurrent depression. If you are planning a pregnancy, book a visit, bring your partner if you like, and we will set a plan with your OB/GYN that covers conception, each trimester, delivery and breastfeeding.

Depression and anxiety in pregnancy

Roughly one in ten women experiences depression during pregnancy, and anxiety is at least as common. Both are under-recognized because fatigue, sleep disruption and appetite change are expected in pregnancy. Treatment matters for two patients: untreated maternal depression is linked to preterm birth, lower birth weight and poorer prenatal self-care, and it is the strongest predictor of postpartum depression. Psychotherapy is effective and is the first choice for mild to moderate symptoms; for moderate to severe symptoms, medication is added, usually an SSRI with a long safety record.

The postpartum period

Postpartum depression can begin any time in the first year and usually within the first three months. It is distinguished from baby blues by duration and depth. Postpartum anxiety and OCD, with intrusive thoughts about harm coming to the baby, are common and deeply distressing, and most women are relieved to learn that intrusive thoughts are a symptom and not a wish. Postpartum psychosis, with confusion, hallucinations and bizarre beliefs, affects about one to two in a thousand births and is an emergency. Women with bipolar disorder are at highest risk and need a plan in place before delivery.

PMDD

Premenstrual dysphoric disorder is a cyclical mood disorder, not a bad attitude about periods. The diagnosis requires prospective tracking because retrospective recall exaggerates or minimizes the pattern. Treatment options include SSRIs taken continuously or only from ovulation to menstruation, combined oral contraceptives containing drospirenone, and CBT. Many women have both PMDD and an underlying depression or anxiety disorder that worsens premenstrually; the tracking helps tell them apart.

Perimenopause and menopause

The years before and around the final menstrual period bring hormonal fluctuation that disrupts sleep, mood and cognition in a substantial minority of women. New-onset depression in a woman in her late forties with changing cycles is perimenopausal until proven otherwise. The approach is collaborative: we treat the mood and sleep disorder, and the gynecologist considers hormone therapy, which can itself improve mood and sleep in the perimenopausal window. CBT-I is particularly useful because sleep disruption drives much of the rest.

Trauma

Sexual assault, intimate partner violence, childhood abuse and traumatic births are common histories among women seeking psychiatric care, and they shape symptoms in ways that are easy to misread as depression or anxiety alone. We ask about trauma at every evaluation, in a way that lets you decide how much to say. Trauma-focused therapies (cognitive processing therapy, prolonged exposure, EMDR through referral) are effective, and medication supports sleep and mood while that work is done.

Frequently asked questions

Is it safe to take antidepressants while pregnant?

For most women with moderate to severe depression or anxiety, yes, and the risks of stopping are usually greater than the risks of continuing. Sertraline has the largest safety record in pregnancy and breastfeeding. We review the evidence for your specific medication, coordinate with your OB/GYN, and document the decision together. Some medications are avoided in pregnancy, and we switch those well before conception when possible.

How do I know if it is baby blues or postpartum depression?

Baby blues are tearfulness, mood swings and irritability in the first two weeks after birth that resolve on their own. Postpartum depression lasts beyond two weeks, deepens, and includes persistent low mood or anxiety, inability to sleep when the baby sleeps, loss of interest, guilt, or intrusive thoughts of harm. If you are past two weeks and not improving, or if you have thoughts of harming yourself or the baby, call us today or use 988.

What is PMDD and how is it different from PMS?

PMDD is a severe form of premenstrual symptoms in which mood (irritability, anxiety, depression, feeling out of control) dominates and significantly disrupts work or relationships during the week before menstruation, resolving within days of onset. PMS is milder and mostly physical. PMDD is a DSM-5-TR diagnosis confirmed by tracking symptoms over two cycles, and it responds well to SSRIs, including luteal-phase-only dosing.

Can perimenopause cause anxiety and depression?

Yes. The menopausal transition, typically the mid-forties to early fifties, roughly doubles the risk of a depressive episode and commonly brings new anxiety, insomnia and concentration problems, often before hot flashes begin. Treatment options include antidepressants, CBT-I for sleep, and hormone therapy coordinated with your gynecologist. Many women are told it is stress; it is worth an evaluation.

Will you work with my OB/GYN?

Yes, with your permission. We communicate directly with your obstetrician, midwife or gynecologist about medication choices during pregnancy and breastfeeding, share the plan before delivery, and align on hormonal treatments that affect mood. If you do not have an OB/GYN, we can recommend one near our offices.

Can I breastfeed on psychiatric medication?

Usually. Most SSRIs, particularly sertraline, pass into breast milk in very small amounts and are considered compatible with breastfeeding. Some medications are less well studied or should be avoided. We review your specific medication using current lactation safety data and coordinate with your pediatrician if there are questions about the infant.

How quickly can a postpartum patient be seen?

Within days in most cases, by video if travel with a newborn is hard. Postpartum depression and anxiety are time-sensitive, and we prioritize these appointments. If you are having thoughts of harming yourself or your baby, or feel confused or are seeing or hearing things that are not there, go to the emergency department or call 911; those are emergencies.

Is women's mental health care covered by insurance?

Yes, as standard psychiatric and therapy visits. Most commercial plans and Medicare cover it at your behavioral health copay, and Medicaid covers pregnancy and postpartum mental health care where our clinicians participate. Self-pay is $185 for a new-patient evaluation and less for follow-ups. Coordination with your OB/GYN is included.

Where this treatment is offered

Conditions this treats

Postpartum Depression and Perinatal Mood Disorders Premenstrual Dysphoric Disorder Perimenopause and Menopause Mood Changes Major Depressive Disorder Generalized Anxiety Disorder Post-Traumatic Stress Disorder Panic Disorder Insomnia Eating Disorders: Anorexia, Bulimia, Binge Eating ADHD in Adults and Children

If you are in crisis, call or text 988 or go to the nearest emergency room. Educational content; individual results vary. Reviewed by Dr. David Husted, board-certified psychiatrist.

Women's Mental Health